Compare Bio Protocol (BIO) vs Orchid (OXT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Orchid — how do they compare? Bio Protocol trades at Rp433.62 (market cap Rp999,49M, Rp162,68M 24h volume), while Orchid trades at Rp164.34 (market cap Rp190,2M, Rp47,84M 24h volume). The key difference: Bio Protocol is far larger — about 5.3× Orchid's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Orchid's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Orchid for 44 Days on average.
| BIO | OXT | |
|---|---|---|
Market Cap | Rp999,49M | Rp190,2M |
Volume (24h) | Rp162,68M | Rp47,84M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 997,2M OXT |
Typical Hold Time | 18 Days | 44 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Orchid (OXT) exhibits a very low market capitalization of Rp190.2M, indicating a micro-cap token with limited market presence. The average hold time of 44 days suggests some short-term accumulation, but the absence of a current price and recent price data limits technical trend analysis. No major protocol updates or significant ecosystem developments have been reported recently, pointing to a period of low network activity.
Overall outlook is highly speculative due to the token's small size and low liquidity. The key opportunity lies in potential future protocol adoption, but major risks include extreme volatility, low trading volume, and the inherent fragility of micro-cap assets in the crypto market. Investors should be aware of the high probability of significant price swings.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Orchid
Orchid describes itself as the world’s first incentivized, peer-to-peer privacy network. Its aim is to overcome internet freedom limitations by using cryptocurrency payments to allow anyone to purchase bandwidth from any participating provider. This is done using so-called probabilistic nanopayments, which occur using OXT, an ERC-20 standard token on Ethereum.
Read more on OXT →
